Mather Group’s Veracyte VCYT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$3.45K Buy
+75
New +$3.62K ﹤0.01% 1908
2025
Q4
– Sell
-175
Closed -$6.01K – 1603
2025
Q3
$6.01K Buy
+175
New +$5.02K ﹤0.01% 1356
2025
Q2
– Sell
-130
Closed -$3.86K – 1670
2025
Q1
$3.86K Buy
+130
New +$4.96K ﹤0.01% 1450
2024
Q3
– Sell
-130
Closed -$2.88K – 2204
2024
Q2
$2.88K Hold
130
– – ﹤0.01% 1784
2024
Q1
$3.58K Buy
+130
New +$3.17K ﹤0.01% 1421

Other funds holding VCYT

Mather Group's VCYT Position: Q3 2026 in Review

Mather Group opened a new position in Veracyte (VCYT) in Q3 2026: 75 shares worth $3.45K. The stake represents ﹤0.01% of the portfolio and ranks #1908 among its holdings. This is a return to the name: Mather Group previously reported a position in VCYT as recently as Q3 2025.

Mather Group first reported a position in VCYT in Q1 2024 and has held it in 5 quarters since. The position peaked at $6.01K in Q3 2025. 49 funds tracked by Wall St. Rank hold VCYT as of Q3 2026.

  • Mather Group held 75 shares of Veracyte worth $3.45K as of Q3 2026.
  • Veracyte was a new Mather Group position in Q3 2026.
  • Veracyte made up ﹤0.01% of Mather Group's portfolio in Q3 2026, its #1908 holding.
  • Mather Group first reported a position in Veracyte in Q1 2024 and has held it in 5 quarters since.
  • Mather Group's Veracyte position peaked at $6.01K in Q3 2025.
  • 49 funds tracked by Wall St. Rank held Veracyte as of Q3 2026.

Based on Mather Group's 13F filing for Q3 2026, filed 14 Oct 2026.